March 20 (Reuters) - Revive Therapeutics Ltd RVV.CD :
* REVIVE THERAPEUTICS EXPLORES THE USE OF BUCILLAMINE AS A NOVEL TREATMENT FOR INFECTIOUS DISEASES INCLUDING COVID-19
March 20 (Reuters) - Revive Therapeutics Ltd RVV.CD :
* REVIVE THERAPEUTICS EXPLORES THE USE OF BUCILLAMINE AS A NOVEL TREATMENT FOR INFECTIOUS DISEASES INCLUDING COVID-19